A single-center long-term experience of active surveillance for prostate cancer: 15 years of follow-up.

Sang Hun Song Jung Kwon Kim Hakmin Lee Sangchul Lee Sung Kyu Hong Seok-Soo Byun

Published in: Investigative and clinical urology (2020)

AS is an available option for low-risk PCa in carefully selected patients. Further larger prospective studies are needed to determine the optimal criteria for AS, especially in Korean PCa patients.

Keyphrases

prostate cancer
end stage renal disease
ejection fraction
newly diagnosed
prognostic factors
radical prostatectomy
patient reported outcomes